Fatty Liver in Inflammatory Bowel Disease (IBD) Patients
Prevalence of Fatty Liver in Inflammatory Bowel Disease (IBD) Patients and Mechanisms Related to Inflammation and Fatty Liver
Sponsor: Tel-Aviv Sourasky Medical Center
Terminated
Lack of budget
Other terminated trials from Tel-Aviv Sourasky Medical Center
A observational or N/A phase clinical study on Fatty Liver and Inflammatory Bowel Disease, this trial is terminated or withdrawn. The trial is conducted by Tel-Aviv Sourasky Medical Center and has accumulated 10 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 5 earlier versions
-
Jul 2020 — Nov 2020 [monthly]
Terminated
Status: Unknown Status → Terminated
-
May 2018 — Jul 2020 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Mar 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tel-Aviv Sourasky Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .